Collegium to Participate in Upcoming Investor Conference
November 08 2019 - 7:00AM
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty
pharmaceutical company committed to being the leader in responsible
pain management, today announced that management will participate
in the following investor conference in November:
- The Jefferies 2019 London Healthcare Conference on Thursday,
November 21st in London. Management will present at 2:00 p.m. GMT
and will also participate in investor meetings.
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to
being the leader in responsible pain management. Collegium’s
headquarters are located in Stoughton, Massachusetts. For more
information, please visit the company’s website at
www.collegiumpharma.com.
Contact: Alex Dasalla adasalla@collegiumpharma.com
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Apr 2024 to May 2024
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From May 2023 to May 2024